Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income/(loss)	$ 4,041	$ (1,765)	$ (29,214)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	14,228	8,926	6,626
Operating lease right-of-use assets amortization expense	4,509	3,192	3,021
Bad debt expense	2,301	945	132
Stock-based compensation	34,167	35,516	60,968
Deferred income taxes	(4,033)	(4,140)	(3,633)
Other (income)/expenses, net	(3,071)	(3,896)	71
Changes in assets and liabilities:
Trade receivable	(9,485)	2,084	(9,854)
Prepaid expenses and other assets	(8,319)	(511)	(3,371)
Accounts payable	(1,503)	(538)	1,729
Accrued compensation and benefits	(274)	5,260	1,694
Operating lease liabilities	(4,542)	(3,135)	(2,574)
Income taxes, net	415	(1,836)	5,075
Accrued expenses and other current liabilities	1,764	991	982
Net cash provided by operating activities	30,198	41,093	31,652
Cash flows from investing activities
Purchase of property and equipment	(11,766)	(7,870)	(6,069)
Proceeds from sale of equity securities	3,581	0	0
Purchase of equity securities	0	(250)	(1,000)
Acquisition of business, net of cash acquired	(43,072)	(17,830)	(9,254)
Other investing activities, net	(44)	0	0
Net cash used in investing activities	(51,301)	(25,950)	(16,323)
Cash flows from financing activities
Proceeds from common stock offering	108,077	0	109,537
Proceeds from exercises of stock options	2,254	510	1,432
Payments of tax obligations resulted from net share settlement of vested stock awards	(8,697)	(16,831)	(5,755)
Equity issuance costs	(472)	0	(253)
Payment of contingent consideration related to previously acquired businesses	0	0	(6,933)
Proceeds from debt	0	0	5,000
Repayment of debt	0	0	(5,000)
Debt issuance cost	0	0	(270)
Net cash provided by/(used in) financing activities	101,162	(16,321)	97,758
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2,131)	1,676	(722)
Net increase in cash, cash equivalents, and restricted cash	77,928	498	112,365
Cash, cash equivalents and restricted cash, beginning of period	257,227	256,729	144,364
Cash, cash equivalents and restricted cash, end of period	335,155	257,227	256,729
Supplemental disclosure of cash flow information:
Cash paid for income taxes	10,967	12,365	7,474
Supplemental disclosure of non-cash activities
Acquisition fair value of contingent consideration issued for acquisition of business	10,180	932	3,288
Balance sheet classification
Cash and cash equivalents	334,655	257,227	256,729
Restricted cash	500	0	0
Total cash, cash equivalents and restricted cash	$ 335,155	$ 257,227	$ 256,729
Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other current assets